Table 3.
Pain | Fatigue | Peripheral Neuropathy | |||||||
---|---|---|---|---|---|---|---|---|---|
Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | |
Intake severity | 0.14 | 78.0 | <0.0001 | 0.10 | 94.9 | <0.0001 | 0.18 | 179.3 | <0.0001 |
Trial Arm | 0.25 | 8.1 | 0.0045* | 0.12 | 4.8 | 0.0290 | 0.15 | 5.6 | 0.0182 |
Cough | Dyspnea | Insomnia | |||||||
Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | |
Intake severity | 0.19 | 135.4 | <0.0001 | 0.17 | 140.5 | <0.0001 | 0.12 | 102.2 | <0.0001 |
Trial Arm | 0.05 | 0.7 | 0.4085 | 0.15 | 5.2 | 0.0223 | 0.02 | 0.04 | 0.8395 |
Dry Mouth | Alopecia | Difficulty Remembering | |||||||
Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | |
Intake severity | 0.12 | 80.8 | <0.0001 | 0.08 | 34.5 | <0.0001 | 0.17 | 125.8 | <0.0001 |
Trial Arm | -0.09 | 1.3 | 0.25 | 0.42 | 23.2 | <0.0001** | -0.08 | 1.3 | 0.2594 |
Poor Appetite | Nausea/Vomiting | Diarrhea | |||||||
Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | |
Intake severity | 0.12 | 98.3 | <0.0001 | 0.14 | 106.2 | <0.0001 | 0.11 | 72.2 | <0.0001 |
Trial Arm | 0.22 | 9.1 | 0.0027** | 0.33 | 21.2 | <0.0001** | 0.19 | 8.1 | 0.0046* |
Constipation | Weakness | ||||||||
Beta | Wald χ2 | P-value | Beta | Wald χ2 | P-value | ||||
Intake severity | 0.12 | 89.1 | <0.0001 | 0.13 | 109.8 | <0.0001 | |||
Trial Arm | 0.35 | 22.0 | <0.0001** | 0.11 | 2.3 | 0.1327 |
Statistically significant according to Benjamini-Hochberg procedure
Statistically significant according to Bonferroni procedure (all comparisons that are significant with Bonferroni procedure are also significant with Benjamini-Hochberg procedure)